EUVIMEDEUVIMED entdecken
Crossref

The Association of ACA on Embryonic Development and Pregnancy Outcomes in Patients Undergoing IVF/ICSI Treatment

Ruochun Lian, Ximin Zhang, Zhiqiang Liu, Cong Chen, Rong Lin, Meilan Mo, Yan Yuan, Yong Zeng iD, Qing Sun, Xian Chen iD

American Journal of Reproductive Immunology · 2024

DOI: 10.1111/aji.70025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Reproductive Immunology, 2024. Verfasst von Ruochun Lian und 9 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen Key Laboratory of Reproductive Immunology for Peri-implantation, Shenzhen Zhongshan Institute for Reproductive Medicine and Genetics, Shenzh…. Hauptthemen laut MEDLINE: Sperm Injections, Intracytoplasmic, Pregnancy Outcome, Embryonic Development, Fertilization in Vitro. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guangdong Basic and Applied Basic Research Foundation, Shenzhen Science and Technology Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To investigate whether anti‐centromere antibody (ACA) is associated with embryonic development and clinical outcomes in patients undergoing IVF/ICSI treatment. Materials and Methods Women who underwent fresh or frozen embryo transfer cycles at a reproductive center between January 1, 2017 and January 1, 2023, were retrospectively studied. Women were divided into ACA– group and ACA+ group according to ACA levels. After controlling the bias between groups using the propensity score‐matching (PSM) method, the impact of ACA on embryonic development and clinical outcomes was compared between the two groups. Propensity score regression adjustment and inverse probability treatment weighting were used for sensitivity analysis.

Results

A total of 18 578 patients with ACA screening information were included in the analytical sample, with 164 patients (0.88%) diagnosing ACA positive. After 1:3 PSM, 656 patients (492 in the ACA– group, 164 in the ACA+ group) were finally included. There were significant differences in the rates of cleavage, available embryo, blastocyst formation, and high‐quality blastocyst formation between the ACA– group and the ACA+ group. Linear regression analysis indicated that ACA was negatively associated with the rates of available embryos on Day 3, blastocyst formation, and high‐quality blastocyst formation after adjusting potential confounding factors. Binary logistic regression analysis suggests that ACA positivity does not affect clinical outcomes after IVF/ICSI treatment.

Conclusions

In this cohort study of patients undergoing IVF/ICSI treatment, ACA positivity significantly interfered with embryonic development. These findings suggest that ACA evaluation before IVF/ICSI treatment might be a promising biomarker for predicting embryonic development but not for clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sperm Injections, IntracytoplasmicPregnancy OutcomeEmbryonic DevelopmentFertilization in VitroHumansFemalePregnancyAdultRetrospective StudiesEmbryo TransferAntibodies, AntinuclearPregnancy Rate

Stichwörter der Autor:innen

IVF/ICSI treatmentanti‐centromere antibodyclinical outcomesembryonic developmentinfertility

Substanzen

Antibodies, Antinuclear

Autor:innen und Institutionen

  • Shenzhen Key Laboratory of Reproductive Immunology for Peri-implantation, Shenzhen Zhongshan Institute for Reproductive Medicine and Genetics, Shenzhen Zhongshan Obstetrics and Gynecology Hospital (formerly Shenzhen Zho…
  • Guangdong Engineering Technology Research Center of Reproductive Immunology for Peri-Implantation, Shenzhen, China.
  • Guangdong Medical University, Dongguan Key Laboratory of Medical Bioactive Molecular Developmental and Translational Research, Guangdong Provincial Key Laboratory of Medical Immunology and Molecular Diagnostics, Donggua…

ORCID-Profile: Yong Zeng, Xian Chen

Förderung

  • National Natural Science Foundation of China
  • Guangdong Basic and Applied Basic Research Foundation
  • Shenzhen Science and Technology Project
  • Shenzhen Medical Research Fund

Zitieren

APA

Lian, R., Zhang, X., Liu, Z., Chen, C., Lin, R., Mo, M., Yuan, Y., Zeng, Y., Sun, Q., & Chen, X. (2024). The Association of ACA on Embryonic Development and Pregnancy Outcomes in Patients Undergoing IVF/ICSI Treatment. American Journal of Reproductive Immunology. https://doi.org/10.1111/aji.70025

Vancouver

Lian R, Zhang X, Liu Z, Chen C, Lin R, Mo M, et al. The Association of ACA on Embryonic Development and Pregnancy Outcomes in Patients Undergoing IVF/ICSI Treatment. American Journal of Reproductive Immunology. 2024. doi:10.1111/aji.70025

BibTeX
@article{Lian2024,
  author = {Lian, Ruochun and Zhang, Ximin and Liu, Zhiqiang and Chen, Cong and Lin, Rong and Mo, Meilan and Yuan, Yan and Zeng, Yong and Sun, Qing and Chen, Xian},
  title = {The Association of ACA on Embryonic Development and Pregnancy Outcomes in Patients Undergoing IVF/ICSI Treatment},
  journal = {American Journal of Reproductive Immunology},
  year = {2024},
  doi = {10.1111/aji.70025}
}
Kostenlos starten →